Akari Therapeutics Plc (AKTX) Operating income 2016–2025
Akari Therapeutics Plc (AKTX) annual operating income history from SEC filings — each fiscal year as reported.
-$17.3MFY2025 · since FY2016: -$27.2M → -$17.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.3M | +20.2% |
| FY2024 | -$21.6M | -28.8% |
| FY2023 | -$16.8M | -41.8% |
| FY2022 | -$11.8M | +31.2% |
| FY2021 | -$17.2M | +4.3% |
| FY2020 | -$18.0M | -6.0% |
| FY2019 | -$17.0M | +18.4% |
| FY2018 | -$20.8M | +45.0% |
| FY2017 | -$37.8M | -38.7% |
| FY2016 | -$27.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice